Abrocitinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Abrocitinib and local guidelines before prescribing.

JAK inhibitor

Mechanism

JAK1 inhibitor.

Uses

Moderate to severe atopic dermatitis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, headache, acne, infections, VTE.

Interactions

CYP2C19 inhibitors raise levels.

Contraindications and cautions

Active infection

Monitoring

FBC, lipids

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

MHRA JAK caution groups.

More from the textbook: uses, cautions and other points
Where it is discussed in the book